(BNOV) Innovator SP500 Buffer - - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • • Defined Outcome

BNOV: Options, ETF, Stocks

The Innovator S&P 500 Buffer ETF - November (BNOV) is a defined outcome ETF that seeks to provide returns based on the performance of the S&P 500, with built-in downside protection. The fund invests at least 80% of its net assets in FLEX Options, which are customizable exchange-traded option contracts referencing the SPDR® S&P 500® ETF Trust (SPY). These FLEX Options are designed to provide a buffer against losses, typically capping downside exposure while offering upside participation up to a predetermined cap. The fund is structured to reset annually, with the November series expiring in November of each year.

FLEX Options are exchange-traded contracts with unique terms, including customizable strike prices, expiration dates, and underlying assets. While they are guaranteed for settlement by the Options Clearing Corporation (OCC), they are subject to counterparty risk with the OCC and may exhibit lower liquidity compared to traditional exchange-traded options. The fund is non-diversified, meaning it can concentrate its investments in a smaller number of securities, which may increase risk.

As of the latest data, BNOV has an average daily trading volume of 20,661 shares, with a last price of $39.27. The funds assets under management (AUM) total $173.80 million, indicating moderate scale and liquidity. Its technical indicators show a short-term SMA (20-day) of $40.02, slightly above its current price, while the SMA 50 and SMA 200 are $39.79 and $38.46, respectively. The ATR (Average True Range) of 0.29 reflects relatively low volatility in recent trading.

3-Month Forecast: - Technical Outlook: BNOVs price is currently below its 20-day SMA but above its 50-day and 200-day SMAs, suggesting a neutral to slightly bullish near-term outlook. The low ATR of 0.29 indicates tight price ranges, with potential resistance near $40.50 and support around $38.50. - Fundamental Outlook: The funds AUM of $173.80 million provides moderate liquidity, which may support stability in the face of market volatility. The S&P 500s performance will remain a key driver of returns, with the funds FLEX Options structure aiming to mitigate downside risk while capping upside potential. Expect the fund to trade within a narrow range, with limited upside but defined downside protection.

Additional Sources for BNOV ETF

BNOV ETF Overview

Market Cap in USD 153m
Category Defined Outcome
TER 0.79%
IPO / Inception 2019-10-31

BNOV ETF Ratings

Growth 5y 78.6%
Fundamental -
Dividend 0.0%
Rel. Strength Industry -4.12
Analysts -
Fair Price Momentum 38.12 USD
Fair Price DCF -

BNOV Dividends

No Dividends Paid

BNOV Growth Ratios

Growth Correlation 3m -7.4%
Growth Correlation 12m 94.2%
Growth Correlation 5y 85.2%
CAGR 5y 12.44%
CAGR/Max DD 5y 0.76
Sharpe Ratio 12m 1.23
Alpha -0.62
Beta 0.39
Volatility 16.98%
Current Volume 19.9k
Average Volume 20d 9.6k
What is the price of BNOV stocks?
As of March 15, 2025, the stock is trading at USD 38.36 with a total of 19,894 shares traded.
Over the past week, the price has changed by -1.54%, over one month by -4.94%, over three months by -3.92% and over the past year by +6.14%.
Is Innovator SP500 Buffer - a good stock to buy?
Yes. Based on ValueRay Analyses, Innovator SP500 Buffer - (BATS:BNOV) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 78.63 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BNOV as of March 2025 is 38.12. This means that BNOV is currently overvalued and has a potential downside of -0.63%.
Is BNOV a buy, sell or hold?
Innovator SP500 Buffer - has no consensus analysts rating.
What are the forecast for BNOV stock price target?
According to ValueRays Forecast Model, BNOV Innovator SP500 Buffer - will be worth about 41.9 in March 2026. The stock is currently trading at 38.36. This means that the stock has a potential upside of +9.28%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 41.9 9.3%